vs
Side-by-side financial comparison of AMREP CORP. (AXR) and FONAR CORP (FONR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $14.6M, roughly 1.8× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs 8.0%, a 13.5% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 2.4%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $-227.0K). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -13.6%).
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
AXR vs FONR — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $25.5M |
| Net Profit | $3.1M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | 20.6% | 13.5% |
| Net Margin | 21.6% | 8.0% |
| Revenue YoY | 93.8% | 2.4% |
| Net Profit YoY | 338.9% | 4.7% |
| EPS (diluted) | $0.58 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $25.5M | ||
| Q3 25 | $17.9M | $26.0M | ||
| Q2 25 | $11.2M | $27.3M | ||
| Q1 25 | $7.5M | $27.2M | ||
| Q4 24 | $11.9M | $24.9M | ||
| Q3 24 | $19.1M | $25.0M | ||
| Q2 24 | $19.5M | $25.9M |
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $2.1M | ||
| Q3 25 | $4.7M | $2.3M | ||
| Q2 25 | $3.9M | $729.3K | ||
| Q1 25 | $717.0K | $2.5M | ||
| Q4 24 | $4.0M | $2.0M | ||
| Q3 24 | $4.1M | $3.1M | ||
| Q2 24 | $4.1M | $830.4K |
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | 13.5% | ||
| Q3 25 | 34.4% | 14.1% | ||
| Q2 25 | 31.7% | 5.3% | ||
| Q1 25 | 5.7% | 15.2% | ||
| Q4 24 | 26.4% | 11.9% | ||
| Q3 24 | 26.1% | 21.0% | ||
| Q2 24 | 23.9% | 7.4% |
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | 8.0% | ||
| Q3 25 | 26.3% | 8.7% | ||
| Q2 25 | 34.8% | 2.7% | ||
| Q1 25 | 9.5% | 9.2% | ||
| Q4 24 | 33.9% | 7.9% | ||
| Q3 24 | 21.3% | 12.6% | ||
| Q2 24 | 21.2% | 3.2% |
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.87 | — | ||
| Q2 25 | $0.73 | — | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $0.75 | — | ||
| Q3 24 | $0.76 | — | ||
| Q2 24 | $0.77 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.0M | $121.0K |
| Total DebtLower is stronger | $21.0K | — |
| Stockholders' EquityBook value | $139.4M | $176.9M |
| Total Assets | $143.9M | $217.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $121.0K | ||
| Q3 25 | $48.9M | $122.0K | ||
| Q2 25 | $39.5M | $56.5M | ||
| Q1 25 | $36.9M | $123.0K | ||
| Q4 24 | $40.1M | $121.0K | ||
| Q3 24 | $40.4M | $136.0K | ||
| Q2 24 | $29.7M | $56.5M |
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | $66.9K |
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $176.9M | ||
| Q3 25 | $134.7M | $174.9M | ||
| Q2 25 | $130.0M | $172.6M | ||
| Q1 25 | $126.0M | $171.9M | ||
| Q4 24 | $125.1M | $169.8M | ||
| Q3 24 | $122.2M | $168.7M | ||
| Q2 24 | $118.0M | $166.0M |
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $217.2M | ||
| Q3 25 | $140.7M | $218.4M | ||
| Q2 25 | $133.8M | $216.9M | ||
| Q1 25 | $128.9M | $214.9M | ||
| Q4 24 | $129.1M | $208.0M | ||
| Q3 24 | $127.0M | $212.3M | ||
| Q2 24 | $122.8M | $214.2M |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $171.0K |
| Free Cash FlowOCF − Capex | $5.4M | $-227.0K |
| FCF MarginFCF / Revenue | 37.0% | -0.9% |
| Capex IntensityCapex / Revenue | 0.1% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.72× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $20.2M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $171.0K | ||
| Q3 25 | $9.5M | $1.7M | ||
| Q2 25 | $10.2M | $4.2M | ||
| Q1 25 | $-3.2M | $3.1M | ||
| Q4 24 | $-182.0K | $2.2M | ||
| Q3 24 | $10.7M | $1.7M | ||
| Q2 24 | $10.7M | $4.6M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-227.0K | ||
| Q3 25 | $9.5M | $-177.0K | ||
| Q2 25 | $9.7M | $3.6M | ||
| Q1 25 | $-3.3M | $2.6M | ||
| Q4 24 | $-268.0K | $1.5M | ||
| Q3 24 | $10.7M | $-148.0K | ||
| Q2 24 | $10.3M | $4.2M |
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | -0.9% | ||
| Q3 25 | 53.2% | -0.7% | ||
| Q2 25 | 86.4% | 13.1% | ||
| Q1 25 | -43.4% | 9.4% | ||
| Q4 24 | -2.3% | 6.0% | ||
| Q3 24 | 55.8% | -0.6% | ||
| Q2 24 | 52.5% | 16.1% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 1.6% | ||
| Q3 25 | 0.1% | 7.2% | ||
| Q2 25 | 5.2% | 2.4% | ||
| Q1 25 | 0.3% | 2.2% | ||
| Q4 24 | 0.7% | 3.0% | ||
| Q3 24 | 0.2% | 7.2% | ||
| Q2 24 | 2.3% | 1.6% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | 0.08× | ||
| Q3 25 | 2.03× | 0.75× | ||
| Q2 25 | 2.63× | 5.79× | ||
| Q1 25 | -4.51× | 1.26× | ||
| Q4 24 | -0.05× | 1.14× | ||
| Q3 24 | 2.63× | 0.53× | ||
| Q2 24 | 2.59× | 5.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXR
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
